These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18535266)

  • 1. The ins and outs of calcium in heart failure.
    O'Rourke B
    Circ Res; 2008 Jun; 102(11):1301-3. PubMed ID: 18535266
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological inhibition of na/ca exchange results in increased cellular Ca2+ load attributable to the predominance of forward mode block.
    Ozdemir S; Bito V; Holemans P; Vinet L; Mercadier JJ; Varro A; Sipido KR
    Circ Res; 2008 Jun; 102(11):1398-405. PubMed ID: 18451338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia-reperfusion injuries.
    Takahashi K; Takahashi T; Suzuki T; Onishi M; Tanaka Y; Hamano-Takahashi A; Ota T; Kameo K; Matsuda T; Baba A
    Eur J Pharmacol; 2003 Jan; 458(1-2):155-62. PubMed ID: 12498920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na+/Ca2+ exchange inhibitors: potential drugs to mitigate the severity of ischemic injury.
    Akabas MH
    Mol Pharmacol; 2004 Jul; 66(1):8-10. PubMed ID: 15213290
    [No Abstract]   [Full Text] [Related]  

  • 5. Is modulation of sodium-calcium exchange a therapeutic option in heart failure?
    Hasenfuss G; Schillinger W
    Circ Res; 2004 Aug; 95(3):225-7. PubMed ID: 15297383
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitor improves force and Ca2 +--frequency relationships in myocytes from rats with heart failure.
    Liao X; He J; Ma H; Tao J; Chen W; Leng X; Mai W; Zhen W; Liu J; Wang L
    Acta Cardiol; 2007 Apr; 62(2):157-62. PubMed ID: 17536604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence Discrimination of Pharmacological Effects on the Na
    Namekata I; Odaka R; Hamazaki S; Nisaka H; Hamaguchi S; Tanaka H
    Biol Pharm Bull; 2021 Jan; 44(1):154-157. PubMed ID: 33132367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral ischemia elicits aberration in myocardium contractile function and intracellular calcium handling.
    Sun L; Ai J; Wang N; Zhang R; Li J; Zhang T; Wu W; Hang P; Lu Y; Yang B
    Cell Physiol Biochem; 2010; 26(3):421-30. PubMed ID: 20798527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthetic preconditioning enhances Ca2+ handling and mechanical and metabolic function elicited by Na+-Ca2+ exchange inhibition in isolated hearts.
    An J; Rhodes SS; Jiang MT; Bosnjak ZJ; Tian M; Stowe DF
    Anesthesiology; 2006 Sep; 105(3):541-9. PubMed ID: 16931987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of dioscin on myocardial contraction and sodium-cal-cium exchanger].
    Yang F; Han Y; Cong TS; Kang Y; Li Y; Sun K; Yin YQ; Lou JS
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Mar; 32(3):209-213. PubMed ID: 29931878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SEA0400 and KB-R7943 on Na+/Ca2+ exchange current and L-type Ca2+ current in canine ventricular cardiomyocytes.
    Birinyi P; Acsai K; Bányász T; Tóth A; Horváth B; Virág L; Szentandrássy N; Magyar J; Varró A; Fülöp F; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):63-70. PubMed ID: 16086157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium calcium exchange as a target for antiarrhythmic therapy.
    Sipido KR; Varro A; Eisner D
    Handb Exp Pharmacol; 2006; (171):159-99. PubMed ID: 16610344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic benefits of targeting the Na+/Ca2+ exchanger.
    Anumonwo J
    Heart Rhythm; 2008 Oct; 5(10):1453-4. PubMed ID: 18929334
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential of Na+/Ca2+ exchange blockers in the treatment of cardiac disease.
    Hobai IA; O'Rourke B
    Expert Opin Investig Drugs; 2004 Jun; 13(6):653-64. PubMed ID: 15174951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes.
    Birinyi P; Tóth A; Jóna I; Acsai K; Almássy J; Nagy N; Prorok J; Gherasim I; Papp Z; Hertelendi Z; Szentandrássy N; Bányász T; Fülöp F; Papp JG; Varró A; Nánási PP; Magyar J
    Cardiovasc Res; 2008 Jun; 78(3):476-84. PubMed ID: 18252759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Na(+)-Ca(2+) exchanger in the failing heart.
    Pogwizd SM
    Circ Res; 2000 Oct; 87(8):641-3. PubMed ID: 11029397
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction by SEA0400 of myocardial ischemia-induced cytoplasmic and mitochondrial Ca2+ overload.
    Namekata I; Shimada H; Kawanishi T; Tanaka H; Shigenobu K
    Eur J Pharmacol; 2006 Aug; 543(1-3):108-15. PubMed ID: 16842776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique excitation-contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+-Ca2+ exchanger.
    Tanaka H; Namekata I; Takeda K; Kazama A; Shimizu Y; Moriwaki R; Hirayama W; Sato A; Kawanishi T; Shigenobu K
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):526-34. PubMed ID: 16003546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockout mice for pharmacological screening: testing the specificity of Na+-Ca2+ exchange inhibitors.
    Reuter H; Henderson SA; Han T; Matsuda T; Baba A; Ross RS; Goldhaber JI; Philipson KD
    Circ Res; 2002 Jul; 91(2):90-2. PubMed ID: 12142340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic effects of Na+/Ca2+ exchanger inhibition in cardiac diseases.
    Tóth A; Kiss L; Varró A; Nánási PP
    Curr Med Chem; 2009; 16(25):3294-321. PubMed ID: 19548864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.